Skip to main content
Equibles

Mark Daniel

CFO

Atossa Therapeutics, Inc. (ATOS)

Chief Accounting Officer

Atossa Therapeutics, Inc. (ATOS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Mark Daniel

Mark Daniel is recorded as CFO and Chief Accounting Officer at Atossa Therapeutics, Inc. (ATOS). Atossa Therapeutics, Inc. reported in an 8-K filed October 14, 2025 that Mark Daniel was appointed principal accounting officer, effective October 14, 2025. Atossa Therapeutics, Inc. reported in an 8-K filed October 14, 2025 that Mark Daniel was appointed Chief Financial Officer, effective October 14, 2025.

“In his role as CFO, Mr. Daniel also will act as the Company's principal accounting officer ("PAO").”
Atossa Therapeutics, Inc. Form 8-K, filed October 14, 2025 · Read the filing
“On October 14, 2025 (the "Effective Date"), Atossa Therapeutics, Inc. (the "Company") announced the appointment of Mr. Mark Daniel as the Chief Financial Officer of the Company ("CFO"), effective immediately.”
Atossa Therapeutics, Inc. Form 8-K, filed October 14, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Atossa Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.